HK1224209A1 - 用於治療癲癇、疼痛、直立性低血壓或眩暈的石杉碱 - Google Patents

用於治療癲癇、疼痛、直立性低血壓或眩暈的石杉碱

Info

Publication number
HK1224209A1
HK1224209A1 HK16112576.9A HK16112576A HK1224209A1 HK 1224209 A1 HK1224209 A1 HK 1224209A1 HK 16112576 A HK16112576 A HK 16112576A HK 1224209 A1 HK1224209 A1 HK 1224209A1
Authority
HK
Hong Kong
Prior art keywords
huperzine
vertigo
pain
orthostatic hypotension
treating seizure
Prior art date
Application number
HK16112576.9A
Other languages
English (en)
Inventor
Steven C Schachter
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of HK1224209A1 publication Critical patent/HK1224209A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
HK16112576.9A 2005-05-23 2016-11-01 用於治療癲癇、疼痛、直立性低血壓或眩暈的石杉碱 HK1224209A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68374505P 2005-05-23 2005-05-23
US75614106P 2006-01-04 2006-01-04

Publications (1)

Publication Number Publication Date
HK1224209A1 true HK1224209A1 (zh) 2017-08-18

Family

ID=37452354

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16112576.9A HK1224209A1 (zh) 2005-05-23 2016-11-01 用於治療癲癇、疼痛、直立性低血壓或眩暈的石杉碱

Country Status (5)

Country Link
US (4) US8193212B2 (zh)
EP (2) EP3056200B1 (zh)
CA (1) CA2609612C (zh)
HK (1) HK1224209A1 (zh)
WO (1) WO2006127748A1 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3056200B1 (en) 2005-05-23 2023-09-06 President and Fellows of Harvard College Huperzine for use in treating seizure
CN1907974B (zh) * 2005-08-01 2010-11-17 天津和美生物技术有限公司 具有镇痛作用的石杉碱甲及其衍生物
US7605265B2 (en) * 2007-01-22 2009-10-20 Biotechnology Research Corporation Ltd. Heterodimers and methods of using them
CN101244026B (zh) * 2007-02-14 2011-03-16 中国科学院上海药物研究所 石杉碱甲及其衍生物或其盐的植入剂、其制备方法及应用
CN101485640B (zh) * 2008-01-18 2011-03-23 普尔药物科技开发（深圳）有限公司 石杉碱甲单层渗透泵控释片
CA2736114A1 (en) * 2008-09-04 2010-03-11 President And Fellows Of Harvard College Treatment of neurological disorders using huperzine
US20110230473A1 (en) * 2008-10-10 2011-09-22 Gordon Richard K Methods and Compositions for Treating Status Epilepticus and Seizures Causing Status Epilepticus
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
ES2847229T3 (es) 2011-03-04 2021-08-02 Univ Yale Compuestos intermedios utilizables en la síntesis de (-)-huperzina y proceso para obtener uno de estos compuestos intermedios
WO2014107685A2 (en) * 2013-01-04 2014-07-10 Insero Health Inc. Compositions and methods for using huperzine and analogs thereof
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
FR3018689B1 (fr) * 2014-03-20 2017-04-28 Centre Hospitalier Univ De Clermont Ferrand Inhibiteurs de l'acetylcholinesterase d'action centrale pour la prevention et/ou le traitement des neuropathies chimio-induites et leurs symptomes, compositions, utilisations, methodes et trousse correspondantes.
CN104116719B (zh) * 2014-07-18 2016-06-22 湖南本草制药有限责任公司 一种石杉碱甲调释片组合物及其制备方法
US10130657B2 (en) * 2015-02-13 2018-11-20 John C. Hughes Formulation, apparatus, and methods for treatment of brain trauma
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
JP2020536955A (ja) 2017-10-06 2020-12-17 ファウンドリー セラピューティクス， インコーポレイテッド 治療剤の制御放出のための埋込み可能なデポー
CN108653290B (zh) * 2018-08-01 2021-04-13 浙江省医学科学院 石杉碱甲在制备治疗或预防癫痫病的经皮给药制剂中的应用
AU2019384130A1 (en) 2018-11-19 2021-04-08 Supernus Pharmaceuticals, Inc. Use of higher doses of modified release huperzine formulations
WO2020191052A1 (en) * 2019-03-19 2020-09-24 Cerecor, Inc. Methods for treating symptomatic orthostatic hypotension

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8405479D0 (sv) * 1984-11-01 1984-11-01 Nilsson Sven Erik Sett att administrera flyktiga, fysiologiskt, aktiva emnen och anordning for detta
US5177082A (en) * 1985-11-05 1993-01-05 Yu Chao Mei Huperzines and analogs
US5316759A (en) * 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
GB8615676D0 (en) * 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
DE3743947A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur gesteuerten abgabe von nicotin, verfahren zu ihrer herstellung sowie ihre verwendung
US4943435A (en) * 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US4839174A (en) * 1987-10-05 1989-06-13 Pharmetrix Corporation Novel transdermal nicotine patch
WO1989004661A1 (en) 1987-11-19 1989-06-01 Indaus International Pty Ltd Nicotine compositions
US5364630A (en) 1988-06-14 1994-11-15 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US4929731A (en) 1989-02-21 1990-05-29 University Of Pittsburgh Method for the synthesis of huperzine A and analogs thereof and compounds useful therein
US5106979A (en) * 1989-02-21 1992-04-21 University Of Pittsburgh Method for the synthesis of huperzine A and analogs thereof and compounds useful therein
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
EP0410236B1 (de) * 1989-07-25 1993-10-27 F. Hoffmann-La Roche Ag Verfahren zur Herstellung von Carotinoidpräparaten
US5230896A (en) * 1989-10-12 1993-07-27 Warner-Lambert Company Transdermal nicotine delivery system
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
US5035252A (en) 1990-12-14 1991-07-30 Mondre Steven J Nicotine-containing dental floss
US5104880A (en) 1991-05-01 1992-04-14 Mayo Foundation For Medical Education And Research Huperzine a analogs as acetylcholinesterase inhibitors
US5293883A (en) 1992-05-04 1994-03-15 Edwards Patrica T Non-combustible anti-smoking device with nicotine impregnated mouthpiece
EP0708627B1 (en) * 1993-07-09 2000-02-02 Cygnus, Inc. Method and device for providing nicotine replacement therapy transdermally/transbuccally
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
USD358683S (en) * 1993-12-03 1995-05-23 Bianco Dominic J Cuticle pusher blade
US5547960A (en) 1994-09-07 1996-08-20 Mayo Foundation For Medical Education And Research C-10 analogs of huperzine a
USRE38460E1 (en) * 1994-12-28 2004-03-09 Shanghai Institute Of Materia Medica Chinese Academy Of Sciences Huperzine A derivatives, their preparation and their use
CN1125725A (zh) * 1994-12-28 1996-07-03 中国科学院上海药物研究所 一类海克林碱衍生物及它的用途
US5954687A (en) * 1995-04-28 1999-09-21 Medtronic, Inc. Burr hole ring with catheter for use as an injection port
US5716635A (en) * 1995-07-19 1998-02-10 M. E. Cody Products, Inc. Plantago major transdermal patch for use in treating a tobacco or nicotine habit
US5725786A (en) * 1995-11-20 1998-03-10 Bayraktaroglu; Burhan Durable mask and method of fabrication
GB9606736D0 (en) * 1996-02-19 1996-06-05 Shire International Licensing Therapeutic method
US5725876A (en) * 1996-05-17 1998-03-10 Noven Pharmaceuticals Inc., Compositions and methods for using low-swell clays in nicotine containing dermal compositions
US5908213A (en) * 1996-10-07 1999-06-01 Tippetts; David R. Elastic door locking device
US5799633A (en) * 1997-08-08 1998-09-01 Lexington Insulators Electrical insulator with a duckbill-shaped valve
US5943435A (en) * 1997-10-07 1999-08-24 Eastman Kodak Company Body part recognition in radiographic images
CA2389865A1 (en) * 1999-11-04 2001-05-10 Xel Herbaceuticals Transdermal administration of huperzine
US20060183776A9 (en) * 2000-03-03 2006-08-17 Eisai Co., Ltd. Liquid dosage formulations of donepezil
US6369052B1 (en) * 2000-08-07 2002-04-09 Georgetown University Combination of huperzine and nicotinic compounds as a neuroprotective agent
US20050129783A1 (en) * 2001-04-19 2005-06-16 Mccleary Edward L. Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health
EP1348466A3 (en) * 2002-02-01 2003-10-29 Inspire Pharmaceuticals, Inc. Method for treating pain with adenosine-tetraphosphates
US8299062B2 (en) * 2003-09-17 2012-10-30 Franklin Volvovitz Pharmaceutical compositions and methods for preventing, treating, or reversing neuronal dysfunction
GB0322140D0 (en) 2003-09-22 2003-10-22 Pfizer Ltd Combinations
WO2005072713A2 (en) * 2004-01-27 2005-08-11 The Feinstein Institute For Medical Research Cholinesterase inhibitors for treating inflammation
AT500143A1 (de) 2004-04-22 2005-11-15 Sanochemia Pharmazeutika Ag Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung
US20060194723A1 (en) * 2005-02-28 2006-08-31 Rabinoff Michael D Novel medication treatment and delivery strategies for Alzheimer's Disease, other disorders with memory impairment, and possible treatment strategies for memory improvement
EP3056200B1 (en) 2005-05-23 2023-09-06 President and Fellows of Harvard College Huperzine for use in treating seizure
CN1709508A (zh) 2005-06-24 2005-12-21 上海赛达生物技术研究中心有限公司 乙酰胆碱酯酶抑制剂在制备治疗糖尿病药物中的应用
CN1907974B (zh) * 2005-08-01 2010-11-17 天津和美生物技术有限公司 具有镇痛作用的石杉碱甲及其衍生物
US20070281961A1 (en) * 2006-06-05 2007-12-06 Brite Age Modified Compositions And Methods For Enhancing Brain Function
US20080064694A1 (en) * 2006-09-11 2008-03-13 Auriga Laboratories, Inc. Multi-Phase Release Methscopolamine Compositions
US20080090808A1 (en) * 2006-10-17 2008-04-17 Franklin Volvovitz Pharmaceutical compositions and methods for preventing, treating, or reversing neuronal dysfunction

Also Published As

Publication number Publication date
US20060264454A1 (en) 2006-11-23
EP3056200B1 (en) 2023-09-06
US8093262B2 (en) 2012-01-10
EP3056200A2 (en) 2016-08-17
US20100234416A1 (en) 2010-09-16
EP1901733A1 (en) 2008-03-26
EP3056200A3 (en) 2016-11-30
CA2609612C (en) 2014-09-23
US8822492B2 (en) 2014-09-02
US20060264455A1 (en) 2006-11-23
CA2609612A1 (en) 2006-11-30
EP1901733B1 (en) 2016-04-06
US20120107392A1 (en) 2012-05-03
EP1901733A4 (en) 2011-06-15
US8193212B2 (en) 2012-06-05
WO2006127748A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
HK1224209A1 (zh) 用於治療癲癇、疼痛、直立性低血壓或眩暈的石杉碱
HK1102758A1 (zh) 膠溶蛋白是用來治療傳染病
TWI347844B (en) Sulfoximine-substituted pyrimidines as cdk-and/or vegf inhibitors, their production and use as pharmaceutical agents
IL183093A0 (en) Methods and compositions for treating pain
IL191118B (en) Ritoxy Mav for use in the treatment of joint damage
IL174994A0 (en) Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy
PL1793842T3 (pl) Leczenie zespołu zmęczenia w chorobie nowotworowej
EP1781329A4 (en) THERAPEUTIC DEVICE AND RELATED ACCESSORIES, COMPOSITIONS AND METHODS OF TREATMENT
EP1636359A4 (en) METHODS OF TREATING PAIN
DE602005006428D1 (de) Wäschebehandlungsmittel
DE602005005702D1 (de) Wäschebehandlungsmittel
DE602005024709D1 (de) Wäschebehandlungsmittel
EP1893190A4 (en) METHODS AND COMPOSITIONS FOR TREATING PAIN
EP1804891A4 (en) CAVITATION-IMPROVED TREATMENT THROUGH LOCAL LEVY
PL1603999T3 (pl) Środek do obróbki tekstyliów
EP1696877A4 (en) PROCESS FOR PAIN TREATMENT
GB2413285B (en) Eye treatment device
EP1835919A4 (en) TREATING DRY EYES
IL180929A0 (en) The use of n-aryl diazaspiracyclic compounds in the treatment of addiction
DE602005008046D1 (de) Wäschebehandlungsmittel
PL1638628T3 (pl) Urządzenie do obróbki krwi
IL184048A0 (en) Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists
GB2430002B (en) Well treatment
EP1663283A4 (en) GLUTAMINE FOR THE TREATMENT OF LESION
IL218241A (en) Galantamine for use in the prevention or treatment of organic phosphorus poisoning